Personalized medicine is a model of healthcare that is predictive, personalized, preventive and participatory (“P4 Medicine”). Genetic counselors are an ideal group to study when designing tools to support cancer P4 Medicine activities more broadly. The goal for this work was to gain a better understanding of the information cancer genetic counselors seek from their patients to facilitate effective information exchange for discussing risk. This was an analysis of a qualitative data set from interviews of eight cancer genetic counselors, recruited from three institutions. Genetic counselors at each site were interviewed using a semi-structured, open-ended questionnaire. A selective coding approach was used to determine major themes associated with genetic counseling information needs for communicating risk. We generated a model for understanding categories of genetic counseling information needs to support risk communication activities. Common activities for risk communication included risk assessment and tailoring communication. Categories of information needs included: (a) clinical patient characteristics, (b) social and cognitive patient characteristics and (c) patient motivation and goals for the genetic counseling session. A logical next step is for this model to inform the design of software systems for pre-visit patient planning and delivering just-in-time educational information to facilitate cancer risk communication activities.
References
[1]
Hood, L.; Flores, M. A personal view on systems medicine and the emergence of proactive P4 medicine: Predictive, preventive, personalized and participatory. N. Biotechnol. 2012, 29, 613–624, doi:10.1016/j.nbt.2012.03.004.
[2]
Escher, M.; Sappino, A.P. Primary care physicians’ knowledge and attitudes towards genetic testing for breast-ovarian cancer predisposition. Ann. Oncol. 2000, 11, 1131–1135, doi:10.1023/A:1008319114278.
[3]
Freedman, A.N.; Wideroff, L.; Olson, L.; Davis, W.; Klabunde, C.; Srinath, K.P.; Reeve, B.B.; Croyle, R.T.; Ballard-Barbash, R. US physicians’ attitudes toward genetic testing for cancer susceptibility. Am. J. Med. Genet. Part A 2003, 120A, 63–71, doi:10.1002/ajmg.a.10192.
[4]
Marzuillo, C.; de Vito, C.; Boccia, S.; D’？？Addario, M.; D’？？Andrea, E.; Santini, P.; Boccia, A.; Villari, P. Knowledge, attitudes and behavior of physicians regarding predictive genetic tests for breast and colorectal cancer. Prev. Med. 2013, doi:10.1016/j.ypmed.2013.06.022.
[5]
Bellcross, C.A.; Kolor, K.; Goddard, K.A.; Coates, R.J.; Reyes, M.; Khoury, M.J. Awareness and utilization of BRCA1/2 testing among U.S. primary care physicians. Am. J. Prev. Med. 2011, 40, 61–66, doi:10.1016/j.amepre.2010.09.027.
[6]
Klitzman, R.; Chung, W.; Marder, K.; Shanmugham, A.; Chin, L.J.; Stark, M.; Leu, C.S.; Appelbaum, P.S. Attitudes and practices among internists concerning genetic testing. J. Genet. Couns 2013, 22, 90–100, doi:10.1007/s10897-012-9504-z.
[7]
Wideroff, L.; Vadaparampil, S.T.; Greene, M.H.; Taplin, S.; Olson, L.; Freedman, A.N. Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians. J. Med. Genet. 2005, 42, 749–755, doi:10.1136/jmg.2004.030296.
[8]
Veach, P.M.; Bartels, D.M.; Leroy, B.S. Coming full circle: A reciprocal-engagement model of genetic counseling practice. J. Genet. Couns. 2007, 16, 713–728, doi:10.1007/s10897-007-9113-4.
[9]
Vos, J.; Stiggelbout, A.M.; Oosterwijk, J.; Gomez-Garcia, E.; Menko, F.; Collee, J.M.; van Asperen, C.J.; Tibben, A. A counselee-oriented perspective on risk communication in genetic counseling: Explaining the inaccuracy of the counselees’ risk perception shortly after BRCA1/2 test result disclosure. Genet. Med. 2011, 13, 800–811, doi:10.1097/GIM.0b013e31821a36f9.
[10]
Miller, S.J.; Hope, T.; Talbot, D.C. The development of a structured rating schedule (the BAS) to assess skills in breaking bad news. Br. J. Cancer 1999, 80, 792–800, doi:10.1038/sj.bjc.6690423.
[11]
Charles, C.; Gafni, A.; Whelan, T. Shared decision-making in the medical encounter: What does it mean? (or it takes at least two to tango). Soc. Sci. Med. 1997, 44, 681–692, doi:10.1016/S0277-9536(96)00221-3.
[12]
Dy, S.M.; Purnell, T.S. Key concepts relevant to quality of complex and shared decision-making in health care: A literature review. Soc. Sci. Med. 2012, 74, 582–587, doi:10.1016/j.socscimed.2011.11.015.
[13]
Yen, P.Y.; Bakken, S. Review of health information technology usability study methodologies. J. Am. Med. Inform. Assoc. 2012, 19, 413–422, doi:10.1136/amiajnl-2010-000020.
[14]
Strauss, A.; Corbin, J. Basics of Qualitative Research: Grounded Theory Procedures and Technique; SAGE: Newbury Park, CA, USA, 1998.
[15]
Gail, M.H.; Brinton, L.A.; Byar, D.P.; Corle, D.K.; Green, S.B.; Schairer, C.; Mulvihill, J.J. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl. Cancer Inst. 1989, 81, 1878–1886.
[16]
Parmigiani, G.; Berry, D.; Aguilar, O. Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am. J. Hum. Genet. 1998, 62, 145–158, doi:10.1086/301670.
[17]
Meiser, B.; Irle, J.; Lobb, E.; Barlow-Stewart, K. Assessment of the content and process of genetic counseling: A critical review of empirical studies. J. Genet. Couns. 2008, 17, 434–451, doi:10.1007/s10897-008-9173-0.
[18]
Pieterse, A.H.; van Dulmen, A.M.; Ausems, M.G.; Beemer, F.A.; Bensing, J.M. Communication in cancer genetic counselling: Does it reflect counselees’ previsit needs and preferences? Br. J. Cancer 2005, 92, 1671–1678, doi:10.1038/sj.bjc.6602570.
[19]
Bernhardt, B.A.; Biesecker, B.B.; Mastromarino, C.L. Goals, benefits, and outcomes of genetic counseling: Client and genetic counselor assessment. Am. J. Med. Genet. 2000, 94, 189–197, doi:10.1002/1096-8628(20000918)94:3<189::AID-AJMG3>3.0.CO;2-E.
[20]
Pieterse, A.; van Dulmen, S.; Ausems, M.; Schoemaker, A.; Beemer, F.; Bensing, J. QUOTE-gene(ca): Development of a counselee-centered instrument to measure needs and preferences in genetic counseling for hereditary cancer. Psychooncology 2005, 14, 361–375, doi:10.1002/pon.853.
[21]
Albada, A.; van Dulmen, S.; Ausems, M.G.; Bensing, J.M. A pre-visit website with question prompt sheet for counselees facilitates communication in the first consultation for breast cancer genetic counseling: Findings from a randomized controlled trial. Genet. Med. 2012, 14, 535–542.
[22]
Belkora, J.; Katapodi, M.; Moore, D.; Franklin, L.; Hopper, K.; Esserman, L. Evaluation of a visit preparation intervention implemented in two rural, underserved counties of Northern California. Patient Educ. Couns. 2006, 64, 350–359, doi:10.1016/j.pec.2006.03.017.
[23]
Sepucha, K.R.; Belkora, J.K.; Aviv, C.; Mutchnik, S.; Esserman, L.J. Improving the quality of decision making in breast cancer: Consultation planning template and consultation recording template. Oncol. Nurs. Forum 2003, 30, 99–106, doi:10.1188/03.ONF.99-106.
